Yu Liu

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · The Lancet Oncology · 2017 · 529 citations

Medicine, Oncology, Pharmacology +10

Ceramide glycosylation potentiates cellular multidrug resistance

Yu Liu, Tie-Yan Han, Armando E. Giuliano et al. · The FASEB Journal · 2001 · 303 citations

Medicine, Oncology, Pharmacology +16

Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer Cells

Yu Liu, Tie-Yan Han, Armando E. Giuliano et al. · Journal of Biological Chemistry · 1999 · 269 citations · Full text

Medicine, Oncology, Pharmacology +14

Prevalence of androgenetic alopecia in China: a community-based study in six cities

T.L. Wang, Cheng Zhou, Yiqi Shen et al. · British Journal of Dermatology · 2010 · 248 citations

Medicine, Dermatology, Endocrinology +10

Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway

Chengliang Yang, Yu Liu, Yegang Ma et al. · PLoS ONE · 2012 · 220 citations · Full text

Medicine, Oncology, Pharmacology +14